140 related articles for article (PubMed ID: 30387480)
21. Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: an attempt towards calcium-sensitive MRI contrast agents.
Mishra A; Fousková P; Angelovski G; Balogh E; Mishra AK; Logothetis NK; Tóth E
Inorg Chem; 2008 Feb; 47(4):1370-81. PubMed ID: 18166011
[TBL] [Abstract][Full Text] [Related]
22. Screening of ligands for redox-active europium using magnetic resonance imaging.
Corbin BA; Basal LA; White SA; Shen Y; Haacke EM; Fishbein KW; Allen MJ
Bioorg Med Chem; 2018 Oct; 26(19):5274-5279. PubMed ID: 29653832
[TBL] [Abstract][Full Text] [Related]
23. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
[TBL] [Abstract][Full Text] [Related]
24. A low-molecular-weight ditopic MRI probe for ratiometric sensing of zwitterionic amino acid neurotransmitters.
Toljić Đ; Angelovski G
Chem Commun (Camb); 2019 Oct; 55(79):11924-11927. PubMed ID: 31528965
[TBL] [Abstract][Full Text] [Related]
25. Gd(III) complexes intercalated into hydroxy double salts as potential MRI contrast agents.
Jin M; Spillane DE; Geraldes CF; Williams GR; Bligh SW
Dalton Trans; 2015 Dec; 44(47):20728-34. PubMed ID: 26568157
[TBL] [Abstract][Full Text] [Related]
26. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
27. Macrocyclic Gd3+ chelates attached to a silsesquioxane core as potential magnetic resonance imaging contrast agents: synthesis, physicochemical characterization, and stability studies.
Henig J; Tóth E; Engelmann J; Gottschalk S; Mayer HA
Inorg Chem; 2010 Jul; 49(13):6124-38. PubMed ID: 20527901
[TBL] [Abstract][Full Text] [Related]
28. Gd-complexes of macrocyclic DTPA conjugates of 1,1'-bis(amino)ferrocenes as high relaxivity MRI blood-pool contrast agents (BPCAs).
Kim HK; Park JA; Kim KM; Nasiruzzaman SM; Kang DS; Lee J; Chang Y; Kim TJ
Chem Commun (Camb); 2010 Nov; 46(44):8442-4. PubMed ID: 20886175
[TBL] [Abstract][Full Text] [Related]
29. Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies.
Lebdusková P; Hermann P; Helm L; Tóth E; Kotek J; Binnemans K; Rudovský J; Lukes I; Merbach AE
Dalton Trans; 2007 Jan; (4):493-501. PubMed ID: 17213936
[TBL] [Abstract][Full Text] [Related]
30. Promising strategies for Gd-based responsive magnetic resonance imaging contrast agents.
Shen C; New EJ
Curr Opin Chem Biol; 2013 Apr; 17(2):158-66. PubMed ID: 23141598
[TBL] [Abstract][Full Text] [Related]
31. Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.
Pierre VC; Botta M; Aime S; Raymond KN
Inorg Chem; 2006 Oct; 45(20):8355-64. PubMed ID: 16999435
[TBL] [Abstract][Full Text] [Related]
32. Importance of outer-sphere and aggregation phenomena in the relaxation properties of phosphonated gadolinium complexes with potential applications as MRI contrast agents.
Elhabiri M; Abada S; Sy M; Nonat A; Choquet P; Esteban-Gómez D; Cassino C; Platas-Iglesias C; Botta M; Charbonnière LJ
Chemistry; 2015 Apr; 21(17):6535-46. PubMed ID: 25754740
[TBL] [Abstract][Full Text] [Related]
33. Switchable MRI contrast agents based on morphological changes of pH-responsive polymers.
Okada S; Mizukami S; Kikuchi K
Bioorg Med Chem; 2012 Jan; 20(2):769-74. PubMed ID: 22206870
[TBL] [Abstract][Full Text] [Related]
34. pH-sensitive modulation of the second hydration sphere in lanthanide(III) tetraamide-DOTA complexes: a novel approach to smart MR contrast media.
Woods M; Zhang S; Ebron VH; Sherry AD
Chemistry; 2003 Oct; 9(19):4634-40. PubMed ID: 14566868
[TBL] [Abstract][Full Text] [Related]
35. Cyclen-based Gd
Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
[TBL] [Abstract][Full Text] [Related]
36. Structure-relaxivity relationships of serum albumin targeted MRI probes based on a single amino acid Gd complex.
Boros E; Caravan P
J Med Chem; 2013 Feb; 56(4):1782-6. PubMed ID: 23391162
[TBL] [Abstract][Full Text] [Related]
37. Improving T₁ and T₂ magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes.
Klemm PJ; Floyd WC; Smiles DE; Fréchet JM; Raymond KN
Contrast Media Mol Imaging; 2012; 7(1):95-9. PubMed ID: 22344885
[TBL] [Abstract][Full Text] [Related]
38. Copper complexes as a source of redox active MRI contrast agents.
Dunbar L; Sowden RJ; Trotter KD; Taylor MK; Smith D; Kennedy AR; Reglinski J; Spickett CM
Biometals; 2015 Oct; 28(5):903-12. PubMed ID: 26253716
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and characterization of dinuclear heterometallic lanthanide complexes exhibiting MRI and luminescence response.
Mamedov I; Parac-Vogt TN; Logothetis NK; Angelovski G
Dalton Trans; 2010 Jun; 39(24):5721-7. PubMed ID: 20485819
[TBL] [Abstract][Full Text] [Related]
40. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
